# Boston Medical Center Corporation – FDA Inspection, Mar 18, 2016

Source: https://www.keypedia.com/records/fda_inspections/boston-medical-center-corporation/81980f7e-039f-430d-b073-5bfd2811ebc3
Source feed: FDA_Inspections

> FDA inspection 963517 of Boston Medical Center Corporation, March 18, 2016. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 606. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 963517
- Company Name: Boston Medical Center Corporation
- Inspection Date: 2016-03-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1270738 - 2025-05-02
- [FDA Inspection 1218229 - 2023-09-12](https://www.keypedia.com/records/fda_inspections/boston-medical-center-corporation/7934772d-2dac-4534-a116-47411800c3ed)
- FDA Inspection 1091871 - 2019-05-16
- FDA Inspection 864614 - 2014-02-03
- [FDA Inspection 759061 - 2011-12-27](https://www.keypedia.com/records/fda_inspections/boston-medical-center-corporation/c613bc98-0104-4b50-8d43-4bb8da652868)

Company: https://www.keypedia.com/companies/boston-medical-center-corporation/559902d3-29a6-4522-a2ac-28231bbc752f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d